NICHE: Nanobody-mediated Immune CHEckpoint imaging and inhibition

Breckpot, Karine (Administrative Promotor)
Thielemans, Kris (Co-Promotor)
Devoogdt, Nick (Co-Promotor)

Description

NICHE: Nanobody-mediated Immune CHEckpoint imaging and inhibition - ANI144

Acronym	ANI144
Status	Finished
Effective start/end date	1/10/15 → 30/09/21

14 Article
4 Poster

Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer
Lecocq, Q., Debie, P., Puttemans, J., Awad, R. M., De Beck, L., Ertveldt, T., De Vlaeminck, Y., Goyvaerts, C., Raes, G., Keyaerts, M., Breckpot, K. & Devoogdt, N., 2 Nov 2021, In: EJNMMI Research. 11, 1, 13 p., 115.
Research output: Contribution to journal › Article › peer-review

Open Access
File
2 Citations (Scopus)

93 Downloads (Pure)
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade
Awad, R. M., Lecocq, Q., Zeven, K., Ertveldt, T., De Beck, L., Ceuppens, H., Broos, K., De Vlaeminck, Y., Goyvaerts, C., Verdonck, M., Raes, G., Van Parys, A., Cauwels, A., Keyaerts, M., Devoogdt, N. & Breckpot, K., 10 Sep 2021, In: Molecular Therapy: Methods & Clinical Development. 22, 9, p. 172-182 11 p., 10.
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Citations (Scopus)

86 Downloads (Pure)
mRNA in cancer immunotherapy: beyond a source of antigen
Van Hoecke, L., Verbeke, R., Dewitte, H., Lentacker, I., Vermaelen, K., Breckpot, K. & Van Lint, S., 3 Mar 2021, In: Molecular Cancer. 20, 1, 14 p., 48.
Research output: Contribution to journal › Article › peer-review

Open Access
File
22 Citations (Scopus)

168 Downloads (Pure)

4 Talk or presentation at a conference
1 Talk or presentation at a workshop/seminar

Noninvasive imaging and inhibition of human programmed death ligand 1 using nanobody K2 to improve cancer immunotherapy
Karine Breckpot (Speaker)
15 Nov 2021
Activity: Talk or presentation › Talk or presentation at a workshop/seminar
Noninvasive imaging and inhibition of human programmed death ligand 1 (PD-L1) using nanobody K2 to improve cancer immunotherapy
Robin Maximilian Awad (Contributor), Dora Mugoli Chigoho (Contributor), Katrijn Broos (Contributor), Quentin Lecocq (Contributor), Katty Zeven (Contributor), Thomas Ertveldt (Contributor), Lien De Beck (Contributor), Hannelore Ceuppens (Contributor), Yannick De Vlaeminck (Contributor), Cleo Goyvaerts (Contributor), Steve Schoonooghe (Contributor), Vicky Caveliers (Contributor), Catarina Xavier (Contributor), Jessica Bridoux (Contributor), Geert Raes (Contributor), Marleen Keyaerts (Contributor), Nick Devoogdt (Contributor) & Karine Breckpot (Speaker)
25 Oct 2021 → 26 Oct 2021
Activity: Talk or presentation › Talk or presentation at a conference

File
Non-invasive immune imaging and cancer immunotherapy using human PD-L1
Karine Breckpot (Speaker)
9 Sep 2021
Activity: Talk or presentation › Talk or presentation at a conference